Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;94(1122):20201272.
doi: 10.1259/bjr.20201272. Epub 2021 May 12.

Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review

Meilinuer Abdurixiti  1 , Mayila Nijiati  2 , Rongfang Shen  1 , Qiu Ya  3 , Naibijiang Abuduxiku  1 , Mayidili Nijiati  3
Affiliations

Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review

Meilinuer Abdurixiti et al. Br J Radiol. .

Abstract

Objectives: To assess the methodological quality of radiomic studies based on positron emission tomography/computed tomography (PET/CT) images predicting epidermal growth factor receptor (EGFR) mutation status in patients with non-small cell lung cancer (NSCLC).

Methods: We systematically searched for eligible studies in the PubMed and Web of Science datasets using the terms "radiomics", "PET/CT", "NSCLC", and "EGFR". The included studies were screened by two reviewers independently. The quality of the radiomic workflow of studies was assessed using the Radiomics Quality Score (RQS). Interclass correlation coefficient (ICC) was used to determine inter rater agreement for the RQS. An overview of the methodologies used in steps of the radiomics workflow and current results are presented.

Results: Six studies were included with sample sizes of 973 ranging from 115 to 248 patients. Methodologies in the radiomic workflow varied greatly. The first-order statistics were the most reproducible features. The RQS scores varied from 13.9 to 47.2%. All studies were scored below 50% due to defects on multiple segmentations, phantom study on all scanners, imaging at multiple time points, cut-off analyses, calibration statistics, prospective study, potential clinical utility, and cost-effectiveness analysis. The ICC results for majority of RQS items were excellent. The ICC for summed RQS was 0.986 [95% confidence interval (CI): 0.898-0.998].

Conclusions: The PET/CT-based radiomics signature could serve as a diagnostic indicator of EGFR mutation status in NSCLC patients. However, the current conclusions should be interpreted with care due to the suboptimal quality of the studies. Consensus for standardization of PET/CT-based radiomic workflow for EGFR mutation status in NSCLC patients is warranted to further improve research.

Advances in knowledge: Radiomics can offer clinicians better insight into the prediction of EGFR mutation status in NSCLC patients, whereas the quality of relative studies should be improved before application to the clinical setting.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of the study selection process
Figure 2.
Figure 2.
Heat map of radiomics quality score (RQS) per component of all included studies.
Figure 3.
Figure 3.
The overlap features among the included studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hsu W-H, Yang JC-H, Mok TS, Loong HH. Overview of current systemic management of EGFR-mutant NSCLC. Ann Oncol 2018; 29(suppl_1): i3–9. doi: 10.1093/annonc/mdx702 - DOI - PubMed
    1. Cheng H, Li X-J, Wang X-J, Chen Z-W, Wang R-Q, Zhong H-C, et al. . A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer. Lung Cancer 2019; 137: 7–13. doi: 10.1016/j.lungcan.2019.08.002 - DOI - PubMed
    1. Tang W, Li X, Xie X, Sun X, Liu J, Zhang J, et al. . Egfr inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations. Lung Cancer 2019; 136: 6–14. doi: 10.1016/j.lungcan.2019.08.001 - DOI - PubMed
    1. Wang S, Shi J, Ye Z, Dong D, Yu D, Zhou M, et al. . Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning. Eur Respir J 2019; 53: 1800986. doi: 10.1183/13993003.00986-2018 - DOI - PMC - PubMed
    1. Cook GJR, Azad G, Owczarczyk K, Siddique M, Goh V. Challenges and promises of PET Radiomics. Int J Radiat Oncol Biol Phys 2018; 102: 1083–9. doi: 10.1016/j.ijrobp.2017.12.268 - DOI - PMC - PubMed

Publication types

MeSH terms